Caplin Point Laboratories Ltd vs Sanofi India Ltd Stock Comparison
Caplin Point Laboratories Ltd vs Sanofi India Ltd Stock Comparison
Last Updated on: May 10, 2026
Key Highlights
The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 1857 as of 08 May 15:30
. The p/e ratio of Caplin Point Laboratories Ltd changed from 12.6 to 28.4 over 5 quarters. This represents a CAGR of 91.58%
The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00%
The market cap of Caplin Point Laboratories Ltd changed from ₹ 3057 crore to ₹ 15222 crore over 5 quarters. This represents a CAGR of 261.19%
The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00%
The revenue of Caplin Point Laboratories Ltd for the Dec '25 is ₹ 576.45 crore as compare to the Sep '25 revenue of ₹ 564.43 crore. This represent the growth of 2.13% The revenue of Sanofi India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Caplin Point Laboratories Ltd for the Dec '25 is ₹ 223.35 crore as compare to the Sep '25 ebitda of ₹ 219.56 crore. This represent the growth of 1.73% The ebitda of Sanofi India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Caplin Point Laboratories Ltd changed from ₹ 124.92 crore to ₹ 165.86 crore over 7 quarters. This represents a CAGR of 17.58%
The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00%
The dividend payout of Caplin Point Laboratories Ltd changed from 14.53 % to 13.43 % over 5 quarters. This represents a CAGR of -6.10%
The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00%
.
About Caplin Point Laboratories Ltd
Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990.
The Company is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections.
Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.
About Sanofi India Ltd
Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.
It has its own manufacturing facility at Goa.
FAQs for the comparison of Caplin Point Laboratories Ltd and Sanofi India Ltd
Which company has a larger market capitalization, Caplin Point Laboratories Ltd or Sanofi India Ltd?
Market cap of Caplin Point Laboratories Ltd is 14,118 Cr while Market cap of Sanofi India Ltd is 8,111 Cr
What are the key factors driving the stock performance of Caplin Point Laboratories Ltd and Sanofi India Ltd?
The stock performance of Caplin Point Laboratories Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Caplin Point Laboratories Ltd and Sanofi India Ltd?
As of May 10, 2026, the Caplin Point Laboratories Ltd stock price is INR ₹1857.35. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.
How do dividend payouts of Caplin Point Laboratories Ltd and Sanofi India Ltd compare?
To compare the dividend payouts of Caplin Point Laboratories Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.